Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Observational Study Evaluating the Influence of Genetic Variants and Cardiometabolic Risk Factors on 10-Year Survival of Biologic Therapies in Patients With Cutaneous Psoriasis With or Without Psoriatic Arthritis

NCT07041112 is registered in ClinicalTrials.gov with Juan Ruano Ruiz as lead sponsor.

NCT NCT07041112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07041112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Observational Study Evaluating the Influence of Genetic Variants and Cardiometabolic Risk Factors on 10-Year Survival of Biologic Therapies in Patients With Cutaneous Psoriasis With or Without Psoriatic Arthritis
Lead sponsor
Juan Ruano Ruiz
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
June 1, 2024
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factors, drug survival, metabolic syndrome (mets), pharmacogenetics, psoriasis, psoriatic arthritis (psa)